NEW YORK — Several Delta Dental dental health plan administrators said on Thursday that they will begin coverage of OraLiva's oral cancer test.

Diagnostics is already operating somewhat separately from the firm's other two business units under its new organizational structure, company officials said.

Chairman and CEO Adam Schechter said that deals may open up as hospital systems grow concerned about Medicaid cuts and the end of Affordable Care Act subsidies.

President and CEO Jim Davis said he believes PAMA reform will pass this year but said another temporary delay will likely be needed to postpone cuts slated for February 1.

The bill was one of several discussed during a Thursday hearing by the Health Subcommittee of the House of Representatives' ...

Sedia's single-use, qualitative immunoassay, called the Asanté HIV-1/2 Oral Fluid Test, detects antibodies to HIV-1 and HIV-2 using oral fluids in as little as 20 minutes and is intended for use by ...

Last week, readers were most interested in a story about concerns about BillionToOne's Unity NIPT due to false negative results.

The physical and digital biobank supports the integration of artificial intelligence in acute care diagnostics development.

The tests run on the company's TruVerus benchtop instrument, which provides results from a blood sample in minutes.

Coupling biomarker-guided screening with a targeted treatment bundle reduced newborn mortality, hospital stays, and other complications over standard care, according to a recent study.

A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.

The firm has developed a whole-blood mRNA test intended for use as a screening tool in women at elevated risk of breast cancer.